Dr Reddys says Sputnik V in final leg of pilot testing, commercial launch soon

Published On 2021-06-17 06:30 GMT   |   Update On 2021-06-17 08:30 GMT

Hyderabad: Dr Reddys Laboratories which has soft-launched Russias COVID-19 vaccine Sputnik V here has expanded the pilot which is in the final leg to other cities such as Mumbai, Bangalore and New Delhi.

Presently it being a limited pilot phase, registration on CoWIN is not open for the public and will become open once the commercial launch is commenced, a press release from Dr Reddy''s said on Wednesday.

The limited pilot soft-launch of the Sputnik V vaccine in India that was initiated by Dr Reddy''s in Hyderabad on May 14 has now been successfully scaled up to other cities such as Visakhapatnam, Bengaluru, Mumbai, Kolkata and Delhi, Baddi, Chennai, Miryalaguda and Kolhapur with more cities to follow in the next few days, Dr Reddy said in an update.

Dr Reddys Laboratories is in a pact with Russian Direct Investment Fund to sell the first 125 million people doses (250 million vials) of Sputnik V in India. The Indian drug-maker recently received nearly three million doses of Sputnik V.

The pilot has allowed Dr Reddys to test the cold storage arrangements of -18C temperature in the cities, CoWIN integration, track and trace and other logistical arrangements ahead of the commercial launch, the release said.

Read also: Dr Reddys, Snowman Logistics collaborate for Sputnik V in India

The limited pilot phase is currently in its final leg as we gear up to ensure a smooth commercial launch, it said.

Adequate number of cold chain units is being deployed and the last mail arrangement is being validated at every partner hospital to ensure seamless storage and handling of the vaccine, Dr Reddys said.

Read also: Dr Reddys, Manipal Hospitals join hands for Sputnik V





Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News